Nasha Zhang

Shandong First Medical University and Shandong Academy of Medical Sciences

H指数:29

被引数:2,920

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CLOCK confers EGFR-TKIs resistance in non-small cell lung cancer by transcriptionally upregulating LAMC2 expression and activating multiple kinase signaling

CLOCK通过转录上调LAMC2表达并激活多种激酶信号通路赋予非小细胞肺癌EGFR-TKIs耐药性

Archives of Biochemistry and Biophysics

IF3

2026-07-010

PRE

Starvation-induced LHFPL3-AS2 promotes MAPKAP K2-dependent phosphorylation of hnRNPA0 and progression of esophageal squamous cell carcinoma

饥饿诱导的LHFPL3-AS2促进MAPKAP K2依赖性的hnRNPA0磷酸化及食管鳞状细胞癌进展

Cancer Letters

IF10.1

2026-02-160

PRE

Non-coding RNAs in gastric cancer: mechanisms and therapeutic prospects

胃癌中的非编码RNA：机制与治疗前景

Molecular Cancer

IF33.9

2025-10-040

OAAI

Oncogenic RBM19 modulated by MAX-mediated allelic transcription regulation in hepatocellular carcinoma progression

致癌RBM19通过MAX介导的等位基因转录调控在肝细胞癌进展中的调节

Archives of Biochemistry and Biophysics

IF3

2025-08-050

PRE

H3K36me3-Guided m6A Modification of Oncogenic L1CAM-AS1 Drives Macrophage Polarization and Immunotherapy Resistance in Hepatocellular Carcinoma

H3K36me3引导的m6A修饰作用于致癌性L1CAM-AS1，驱动巨噬细胞极化及肝癌免疫治疗抵抗

Advanced Science

IF14.1

2025-06-190

OAAI

Integrated functional genomics-identified LYRM4 promotes fumarate accumulation and hepatocellular carcinoma progression

整合功能基因组学鉴定的LYRM4促进富马酸积累和肝细胞癌进展

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

IF3

2025-06-040

PRE

WDR11-DT enhances radiosensitivity via promoting PARP1 degradation and homologous recombination deficiency

WDR11-DT通过促进PARP1降解和同源重组缺陷来增强放射敏感性。

CANCER LETTERS

IF10.1

2025-06-040

PRE

Integrated functional genomics-identified DEAF1 in oxidative stress and hepatocellular carcinoma development

整合功能基因组学鉴定的DEAF1在氧化应激和肝细胞癌发展中的作用

CARCINOGENESIS

IF2.9

2025-02-011

PRE

MAZ promotes thyroid cancer progression by driving transcriptional reprogram and enhancing ERK1/2 activation

CANCER LETTERS

IF10.1

2024-10-011

PRE

Circular RNAs in lung cancer: implications for preventing therapeutic resistance

EBIOMEDICINE

IF10.8

2024-09-010

OAAI

The TDP-43/TP63 Positive Feedback Circuit Promotes Esophageal Squamous Cell Carcinoma Progression

TDP-43/TP63正反馈回路促进食管鳞癌进展

ADVANCED SCIENCE

IF14.1

2024-07-180

Genome-wide functional integration identified MAZ-controlled RPS14 dysregulation in hepatocellular carcinoma

ARCHIVES OF TOXICOLOGY

IF6.9

2024-01-081

PRE

Super-enhancers: Implications in gastric cancer

ageing research reviews

IF4.2

2024-01-011

PRE

LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation

CELL REPORTS

IF6.9

2023-12-012

LINC01226 promotes gastric cancer progression through enhancing cytoplasm-to-nucleus translocation of STIP1 and stabilizing β-catenin protein

CANCER LETTERS

IF10.1

2023-11-0112

PRE

Long non-coding RNAs in non-small cell lung cancer: implications for preventing therapeutic resistance

非小细胞肺癌中的长链非编码rna: 预防治疗耐药性的意义

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

IF8.3

2023-11-012

PRE

The ASH1L-AS1-ASH1L axis controls NME1-mediated activation of the RAS signaling in gastric cancer

ONCOGENE

IF7.3

2023-10-079

PRE

Inflammatory cytokine-regulated LNCPTCTS suppresses thyroid cancer progression via enhancing Snail nuclear export

CANCER LETTERS

IF10.1

2023-10-017

Super Enhancer-Regulated LncRNA LINC01089 Induces Alternative Splicing of DIAPH3 to Drive Hepatocellular Carcinoma Metastasis

CANCER RESEARCH

IF16.6

2023-09-2615

PRE

LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2023-04-1816

OAAI

Nasha Zhang

个人简介

教育背景

工作经历

荣誉奖项

研究方向